methylprednisolone hemisuccinate has been researched along with tretinoin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Brown, DC; Larson, RS; Sklar, LA | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and tretinoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2.
Topics: Antibodies, Monoclonal; Antigens, CD; Antineoplastic Agents; Cell Adhesion Molecules; Cell Aggregation; Cell Differentiation; Edetic Acid; Humans; Integrin alpha4beta1; Integrins; Leukemia, Promyelocytic, Acute; Lymphocyte Function-Associated Antigen-1; Methylprednisolone Hemisuccinate; Neoplasm Proteins; Neoplastic Stem Cells; Receptors, Lymphocyte Homing; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1997 |